SER Group, a leading provider of Intelligent Content Automation solutions with its highly rated Doxis platform, today announced the acquisition of AFI Solutions, a specialist in the digitalization and ...

Neuron23® Inc., a clinical-stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases, today announced the publication of a ...

From sonic tomographies to global biodiversity negotiations, this journey through research, resilience, and connection ...

Plastic is everywhere. And many products we use in everyday life can expose people to tiny, micrometer-wide plastic particles ...

The global conversational AI market, valued at USD 6.9 billion in 2021, is projected to grow at a robust compound annual growth rate (CAGR) of 23.4%, reaching approximately USD 29.9 billion by 2028.

Fusing a world-class ecosystem with cutting-edge technology, the UK is setting a new standard for innovation in life sciences ...

Women are severely underrepresented in top leadership roles across the business world. Only 10.4% of the Fortune 500 ...

Staying hydrated in summer isn’t just about guzzling litres of water. Too little can sap your energy, while too much can ...

The agency OK’d an artificial vessel to restore blood flow in patients, even though its own scientists flagged questionable ...

With its move to MIT’s Volpe Center in Kendall Square, the drugmaker is consolidating its local footprint from three buildings to one.

Made by combining several emerging technologies, human “bodyoids” could reduce animal testing, improve drug development, and alleviate organ shortages.

Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine ...